• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 774

Glutaminase from Bacillus licheniformis produced in Bacillus licheniformis

Intended Use: Intended for use as a processing aid in various food ingredients such as casein, whey protein, soy and wheat protein, breads, noodles, tofu, fish, cheese and seasonings at levels that are the minimum amount necessary to achieve the desired technical effect.
Basis: Scientific procedures
Notifier: Novozymes North America, Inc.
Notifier Address: 77 Perrys Chapel Church Road, Box 576
Franklinton, NC 27525
GRAS Notice (releasable information): GRN 774 (in PDF) (1.3 MB)
Date of closure: Nov 26, 2018
FDA's Letter: FDA has no questions (in PDF) (73 kB)